NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

WTF Smitty?!?!

You said "massive revenues" were a prerequisite before Wall Street engages/invests in NWBO. Where in your post did you say anything that is even remotely supportive of the phrase, "until these things happen"?

"And how you become a Wallstreet Darling is by generating massive amount a revenue end related profits. We are a few years away from that."

Second, I responded that I doubted the generation of massive revenues by NWBO would take a long time and that Wall Street already recognizes the ultimate potential of DCVax, which is why they have manipulated the stock for more than a decade. The point I made was that massive revenues were not required as Wall Street was already investing millions suppressing NWBO stock, which was proof-positive that they were aware of the competition DCVax would likely bring to the legacy pharmaceuticals they had invested in (Click to see post):

It may take some time for NWBO to generate "massive" revenues (I doubt it) but it will take no time at all for Wall-street to recognize the ultimate potential of DCVax-L. In fact, wall-street already knows, which is why they have deliberately manipulated NWBO's stock price through spoofing and other means for decades, causing the company to sell shares at artificially depressed prices.

Why would wall-street money-makers, hedge funds deliberately manipulate NWBO's stock price deliberately for a decade+? The answer can easily be found by examining NWBO's lawsuit plaintiffs. All of the money-makers involved own hedge funds that are heavily invested in legacy pharma companies to the tune of $12 billion. The problem is not that wall street doesn't know about DCVax and its ultimate potential. The problem is they really believed they could bankrupt NWBO but are now recognizing that they lost and need to switch positions wrt NWBO? I speculate that this position-change is underway now and will accelerate after approval and major BP partnership announced. Directly thereafter NWBO's pps will explode!

Smitty5150, again, my only point is very specific:

"massive revenues" are not necessary for wall-street to get on the NWBO train in a substantial way. MHRA approval AND big pharma multiple partnerships would be a clear indication of minimized risks. Furthermore, the fact that DCVax is the best or only game in town for all cancer tumors, NWBO has dendritic cells on lock-down with patents galore and ,via Eden, can scale infinitely, lowers risk even more (even if you hold the view that DCVax agnostic designation will be achieved later). NWBO will NOT need massive revenues before wall-street invests significant $$$.

In simpler terms: MHRA approval + multiple big-pharma partnerships = minimized risk = significant investment into NWBO BEFORE massive revenues are in the picture.

Add the likelihood of DCVax-L (perhaps with combo) becoming SOC and the infinite mfg. scalability that comes with Eden, to this equation. It is ludicrous for you to think Wall-street would walk away from this.